{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:21:54Z","timestamp":1794025314877,"version":"4.8.0"},"reference-count":401,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of this common arrhythmia. Substantial advances in the epidemiology and associated pathophysiology underlying AF-related stroke and thrombo-embolism are evident. Furthermore, the introduction of the non-vitamin K antagonist oral anticoagulants (also called direct oral anticoagulants) has clearly changed our approach to stroke prevention in AF, such that the default should be to offer oral anticoagulation for stroke prevention, unless the patient is at low risk. A strategy of early rhythm control is also beneficial in reducing strokes in selected patients with recent onset AF, when compared to rate control. Cardiovascular risk factor management, with optimization of comorbidities and attention to lifestyle factors, and the patient\u2019s psychological morbidity are also essential. Finally, in selected patients with absolute contraindications to long-term oral anticoagulation, left atrial appendage occlusion or exclusion may be considered. The aim of this state-of-the-art review article is to provide an overview of the current status of AF-related stroke and prevention strategies. A holistic or integrated care approach to AF management is recommended to minimize the risk of stroke in patients with AF, based on the evidence-based Atrial fibrillation Better Care (ABC) pathway, as follows: A: Avoid stroke with Anticoagulation; B: Better patient-centred, symptom-directed decisions on rate or rhythm control; C: Cardiovascular risk factor and comorbidity optimization, including lifestyle changes.<\/jats:p>","DOI":"10.1093\/europace\/euad226","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T09:00:47Z","timestamp":1689930047000},"source":"Crossref","is-referenced-by-count":165,"title":["Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"first","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool , UK"},{"name":"Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University , Aalborg , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-2478","authenticated-orcid":false,"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, University of Milan , Milan , Italy"},{"name":"Division of Subacute Care, IRCCS Istituti Clinici Scientifici Maugeri , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-6902","authenticated-orcid":false,"given":"Tatjana","family":"Potpara","sequence":"additional","affiliation":[{"name":"School of Medicine, Belgrade University , Belgrade , Serbia"},{"name":"Cardiology Clinic, University Clinical Centre of Serbia , Belgrade , Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Mansour","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Savelieva","sequence":"additional","affiliation":[{"name":"Clinical Academic Group, Molecular and Clinical Sciences Institute, St. George\u2019s University of London , Cranmer Terrace London SW17 0RE , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-7808","authenticated-orcid":false,"given":"Hung Fat","family":"Tse","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong , Hong Kong , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8223-7209","authenticated-orcid":false,"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II: Kardiologie und Intensivmedizin, St. Vincenz-Krankenhaus Paderborn , Am Busdorf 2, 33098 Paderborn , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-2871","authenticated-orcid":false,"given":"A John","family":"Camm","sequence":"additional","affiliation":[{"name":"Clinical Academic Group, Molecular and Clinical Sciences Institute, St. George\u2019s University of London , Cranmer Terrace London SW17 0RE , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2806-3903","authenticated-orcid":false,"given":"Carina","family":"Blomstrom-Lundqvist","sequence":"additional","affiliation":[{"name":"Department of Cardiology, School of Medical Sciences, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3490-090X","authenticated-orcid":false,"given":"Dhiraj","family":"Gupta","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital , Liverpool , UK"},{"name":"Department of Cardiology, Liverpool Heart & Chest Hospital , Liverpool , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena , via del Pozzo 71, 41125 Modena , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"key":"2023083100271197500_euad226-B1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2023083100271197500_euad226-B2","first-page":"793","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2019","volume-title":"Europace","year":"2023"},{"key":"2023083100271197500_euad226-B3","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham heart study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"2023083100271197500_euad226-B5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B6","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2023083100271197500_euad226-B7","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"34","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B8","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/europace\/euz141","article-title":"Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI project","volume":"21","author":"Di Carlo","year":"2019","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.hlc.2017.05.120","article-title":"Epidemiology of atrial fibrillation: the Australian and Asia-Pacific perspective","volume":"26","author":"Wong","year":"2017","journal-title":"Heart Lung Circ"},{"key":"2023083100271197500_euad226-B10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan nationwide AF cohort study","volume":"153","author":"Chao","year":"2018","journal-title":"Chest"},{"key":"2023083100271197500_euad226-B11","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1137230","article-title":"Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the global burden of disease study 2019","volume":"11","author":"Jiao","year":"2023","journal-title":"Front Public Health"},{"key":"2023083100271197500_euad226-B12","doi-asserted-by":"crossref","first-page":"16016","DOI":"10.1038\/nrdp.2016.16","article-title":"Atrial fibrillation","volume":"2","author":"Lip","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2023083100271197500_euad226-B13","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.tcm.2021.10.001","article-title":"Stroke prevention in atrial fibrillation","volume":"32","author":"Lip","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"2023083100271197500_euad226-B16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2018.07.044","article-title":"Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients","volume":"269","author":"Marzona","year":"2018","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA(2)DS(2)-VA score rather than CHA(2)DS(2)-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1055\/s-0040-1710014","article-title":"Female sex as a risk modifier for stroke risk in atrial fibrillation: using CHA2DS2-VASc versus CHA2DS2-VA for stroke risk stratification in atrial fibrillation: a note of caution","volume":"120","author":"Nielsen","year":"2020","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/1060028020904969","article-title":"The tasmanian atrial fibrillation study (TAFS): differences in stroke prevention according to sex","volume":"54","author":"Pilcher","year":"2020","journal-title":"Ann Pharmacother"},{"key":"2023083100271197500_euad226-B20","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B21","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B22","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/STROKEAHA.118.024305","article-title":"Refining stroke and bleeding prediction in atrial fibrillation by adding consecutive biomarkers to clinical risk scores","volume":"50","author":"Rivera-Caravaca","year":"2019","journal-title":"Stroke"},{"key":"2023083100271197500_euad226-B23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1055\/s-0040-1712914","article-title":"Predicting adverse events beyond stroke and bleeding with the ABC-stroke and ABC-bleeding scores in patients with atrial fibrillation: the murcia AF project","volume":"120","author":"Camelo-Castillo","year":"2020","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1160\/TH17-07-0478","article-title":"Long-term bleeding risk prediction in \u2018real world\u2019 patients with atrial fibrillation: comparison of the HAS-BLED and ABC-bleeding risk scores. The murcia atrial fibrillation project","volume":"117","author":"Esteve-Pastor","year":"2017","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006490","article-title":"Long-term stroke risk prediction in patients with atrial fibrillation: comparison of the ABC-stroke and CHA(2)DS(2)-VASc scores","volume":"6","author":"Rivera-Caravaca","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/FJC.0000000000000750","article-title":"Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation","volume":"74","author":"Domek","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"2023083100271197500_euad226-B27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/a-1467-2993","article-title":"Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","article-title":"Atrial fibrillation and the prothrombotic state: revisiting virchow's triad in 2020","volume":"106","author":"Ding","year":"2020","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2022.12.007","article-title":"Imaging in atrial fibrillation: a way to assess atrial fibrosis and remodeling to assist decision-making","volume":"258","author":"L\u00f3pez-Galvez","year":"2023","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002197","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific heart rhythm society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018atrial fibrillation better care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B33","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/europace\/euac082","article-title":"Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial","volume":"24","author":"Patel","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014932","article-title":"Comprehensive management with the ABC (atrial fibrillation better care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial","volume":"9","author":"Proietti","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B35","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":". Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B36","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","author":"Romiti","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B37","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1093\/eurheartj\/ehac265","article-title":"A multinational European network to implement integrated care in elderly multimorbid atrial fibrillation patients: the AFFIRMO consortium","volume":"43","author":"Johnsen","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B38","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (section III). Position paper of the ESC working group on thrombosis\u2013task force on anticoagulants in heart disease","volume":"110","author":"De Caterina","year":"2013","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0038-1641166","article-title":"Comparing non-vitamin K antagonist oral anticoagulants (NOACs) to different coumadins: the win-win scenarios","volume":"118","author":"Potpara","year":"2018","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B40","first-page":"833","article-title":"Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry","volume":"111","author":"Le Heuzey","year":"2014","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1160\/TH16-10-0807","article-title":"New developments in anticoagulants: past, present and future","volume":"117","author":"Weitz","year":"2017","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B42","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2023083100271197500_euad226-B43","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2023083100271197500_euad226-B45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B48","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/fca-2021-0120","article-title":"Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis","volume":"18","author":"Deitelzweig","year":"2022","journal-title":"Future Cardiol"},{"key":"2023083100271197500_euad226-B50","doi-asserted-by":"crossref","first-page":"A42","DOI":"10.1093\/eurheartj\/suab152","article-title":"Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation","volume":"24","author":"Farinha","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"2023083100271197500_euad226-B51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"Ozaki","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2023083100271197500_euad226-B52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/heartjnl-2022-321114","article-title":"Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"109","author":"Caso","year":"2023","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B53","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B54","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B55","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300067","article-title":"Apixaban or warfarin in patients with an on-X mechanical aortic valve","volume":"2","author":"Wang","year":"2023","journal-title":"NEJM Evidence"},{"key":"2023083100271197500_euad226-B56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40256-020-00449-3","article-title":"Rivaroxaban versus warfarin in patients with mechanical heart valves: open-label, proof-of-concept trial-the RIWA study","volume":"21","author":"Duraes","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"2023083100271197500_euad226-B57","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1093\/eurheartj\/suab151","article-title":"Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease","volume":"24","author":"Fanaroff","year":"2022","journal-title":"Eur Heart J Suppl"},{"key":"2023083100271197500_euad226-B58","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2018.12.047","article-title":"Outcomes of direct oral anticoagulants in patients with mitral stenosis","volume":"73","author":"Kim","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B59","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease-associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B60","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038194","article-title":"Protocol, rationale and design of DAbigatran for stroke PreVention in atrial fibrillation in MoDerate or severe mitral stenosis (DAVID-MS): a randomised, open-label study","volume":"10","author":"Zhou","year":"2020","journal-title":"BMJ Open"},{"key":"2023083100271197500_euad226-B61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B62","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A randomized controlled trial comparing apixaban with the vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B64","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2020111566","article-title":"Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial","volume":"32","author":"De Vriese","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2023083100271197500_euad226-B65","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jacc.2016.12.031","article-title":"Valvular heart disease patients on edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial","volume":"69","author":"De Caterina","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B66","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","article-title":"Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"132","author":"Avezum","year":"2015","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B67","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa2029603","article-title":"Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve","volume":"383","author":"Guimaraes","year":"2020","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B68","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B69","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B70","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.jtcvs.2021.07.034","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: a meta-analysis","volume":"165","author":"Yokoyama","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2023083100271197500_euad226-B71","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B72","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B73","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2022.11.057","article-title":"Clinical evaluation of factor XIa inhibitor drugs: JACC review topic of the week","volume":"81","author":"Harrington","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B74","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The east Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B76","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1055\/a-1789-4824","article-title":"Managing uncertainty: physicians\u2019 decision making for stroke prevention for patients with atrial fibrillation and intracerebral hemorrhage","volume":"122","author":"Ivany","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B77","doi-asserted-by":"crossref","first-page":"257s","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"key":"2023083100271197500_euad226-B78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.0954-6820.1969.tb07351.x","article-title":"Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material","volume":"185","author":"Aberg","year":"1969","journal-title":"Acta Med Scand"},{"key":"2023083100271197500_euad226-B79","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1136\/heartjnl-2012-301799","article-title":"Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure","volume":"98","author":"Mahajan","year":"2012","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B80","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ejcts\/ezu291","article-title":"Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis","volume":"47","author":"Tsai","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2023083100271197500_euad226-B81","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B82","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1161\/01.CIR.0000015605.30810.51","article-title":"Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model","volume":"105","author":"Nakai","year":"2002","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B83","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B85","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B86","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/eurheartj\/ehw048","article-title":"Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation","volume":"37","author":"Panikker","year":"2016","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B87","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials","volume":"76","author":"Turagam","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B88","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B89","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013525","article-title":"Net clinical benefit of left atrial appendage closure versus warfarin in patients with atrial fibrillation: a pooled analysis of the randomized PROTECT-AF and PREVAIL studies","volume":"8","author":"Brouwer","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B90","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the amplatzer\u2122 amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B91","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijcard.2017.02.042","article-title":"Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: results from the amplatzer cardiac plug registry","volume":"236","author":"Tzikas","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B92","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B93","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.recesp.2019.02.009","article-title":"Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry","volume":"73","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2023083100271197500_euad226-B95","first-page":"314","article-title":"Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients","volume":"21","author":"Zhai","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"2023083100271197500_euad226-B96","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/eurheartj\/ehu048","article-title":"Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial","volume":"35","author":"Coppens","year":"2014","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B97","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0040-1717115","article-title":"Long-term treatment with apixaban in patients with atrial fibrillation: outcomes during the open-label extension following AVERROES","volume":"121","author":"Benz","year":"2021","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1474-4422(12)70017-0","article-title":"Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial","volume":"11","author":"Diener","year":"2012","journal-title":"Lancet Neurol"},{"key":"2023083100271197500_euad226-B99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2023083100271197500_euad226-B100","first-page":"128","article-title":"Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials","volume":"59","author":"Hanif","year":"2018","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2023083100271197500_euad226-B101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/heartjnl-2016-309782","article-title":"Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials","volume":"103","author":"Sahay","year":"2017","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B102","first-page":"242","article-title":"Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: a multicenter registry","volume":"16","author":"Krittayaphong","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"2023083100271197500_euad226-B103","first-page":"465","article-title":"Evaluation of patients\u2019 attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"Lahaye","year":"2014","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/STROKEAHA.109.566950","article-title":"Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke","volume":"41","author":"Glader","year":"2010","journal-title":"Stroke"},{"key":"2023083100271197500_euad226-B105","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1161\/STROKEAHA.119.025464","article-title":"Younger age and depressive symptoms predict high risk of generalized anxiety after stroke and transient ischemic attack","volume":"50","author":"Kapoor","year":"2019","journal-title":"Stroke"},{"key":"2023083100271197500_euad226-B106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.recesp.2019.02.018","article-title":"Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). results from the amplatzer cardiac plug registry","volume":"73","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2023083100271197500_euad226-B107","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ene.13894","article-title":"Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke","volume":"26","author":"Masjuan","year":"2019","journal-title":"Eur J Neurol"},{"key":"2023083100271197500_euad226-B108","first-page":"212","article-title":"Left atrial appendage occlusion as adjunctive therapy to anticoagulation for stroke recurrence","volume":"31","author":"Freixa","year":"2019","journal-title":"J Invasive Cardiol"},{"key":"2023083100271197500_euad226-B109","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B110","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"key":"2023083100271197500_euad226-B111","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/joa3.12652","article-title":"2021 focused update of the 2017 consensus guidelines of the Asia pacific heart rhythm society (APHRS) on stroke prevention in atrial fibrillation","volume":"37","author":"Chao","year":"2021","journal-title":"J Arrhythm"},{"key":"2023083100271197500_euad226-B112","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.hlc.2018.06.1043","article-title":"National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018","volume":"27","author":"Brieger","year":"2018","journal-title":"Heart Lung Circ"},{"key":"2023083100271197500_euad226-B113","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"2023083100271197500_euad226-B114","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/europace\/euu174","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"16","author":"Meier","year":"2014","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B115","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B116","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B117","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B118","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B119","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B120","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2013pharmacological intervention in atrial fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"2023083100271197500_euad226-B121","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the strategies of treatment of atrial fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B122","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish how to treat chronic atrial fibrillation (HOT CAFE) study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"2023083100271197500_euad226-B123","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1253\/circj.CJ-08-0608","article-title":"Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study","volume":"73","author":"Ogawa","year":"2009","journal-title":"Circ J"},{"key":"2023083100271197500_euad226-B124","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0195-668X(03)00261-6","article-title":"Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study","volume":"24","author":"Gr\u00f6nefeld","year":"2003","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B125","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/euhj.2001.2971","article-title":"An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation","volume":"23","author":"Brignole","year":"2002","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jacep.2015.11.001","article-title":"Rhythm control versus rate control and clinical outcomes in patients with atrial fibrillation: results from the ORBIT-AF registry","volume":"2","author":"Noheria","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"2023083100271197500_euad226-B127","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (registry on cardiac rhythm disorders assessing the control of atrial fibrillation)","volume":"58","author":"Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cjco.2022.03.001","article-title":"Rhythm control vs rate control in a contemporary ambulatory atrial fibrillation cohort: post hoc analysis of the IMPACT-AF trial","volume":"4","author":"Govindapillai","year":"2022","journal-title":"CJC Open"},{"key":"2023083100271197500_euad226-B129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10840-020-00856-1","article-title":"Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial","volume":"61","author":"Zhao","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"2023083100271197500_euad226-B130","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"2023083100271197500_euad226-B131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B132","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ejhf.2714","article-title":"Long-term outcomes following catheter ablation versus medical therapy in patients with persistent atrial fibrillation and heart failure with reduced ejection fraction","volume":"25","author":"Zakeri","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2023083100271197500_euad226-B133","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B134","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.hrthm.2013.07.002","article-title":"Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score","volume":"10","author":"Bunch","year":"2013","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B135","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B136","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jacc.2010.01.023","article-title":"Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation","volume":"55","author":"Talajic","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B137","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/europace\/euab185","article-title":"Catheter ablation vs. antiarrhythmic drugs as \u2018first-line\u2019 initial therapy for atrial fibrillation: a pooled analysis of randomized data","volume":"23","author":"Chen","year":"2021","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B138","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/europace\/eux275","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B139","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1093\/eurheartj\/ehz443","article-title":"Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B141","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.hrthm.2020.02.030","article-title":"Generalizability of the CASTLE-AF trial: catheter ablation for patients with atrial fibrillation and heart failure in routine practice","volume":"17","author":"Noseworthy","year":"2020","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B142","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B143","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.112.092494","article-title":"Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation","volume":"126","author":"Tsadok","year":"2012","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B144","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2009.11.039","article-title":"The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation","volume":"55","author":"Themistoclakis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1540-8167.2011.02035.x","article-title":"Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation","volume":"22","author":"Bunch","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B146","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00392-021-01914-y","article-title":"Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF long-term general registry","volume":"111","author":"Proietti","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"2023083100271197500_euad226-B147","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1055\/a-1807-0336","article-title":"Early rhythm control and the risks of ischemic stroke, heart failure, mortality, and adverse events when performed early (&lt; 3 months): a nationwide cohort study of newly diagnosed patients with atrial fibrillation","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B148","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12916-022-02545-4","article-title":"Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"20","author":"Zhu","year":"2022","journal-title":"BMC Med"},{"key":"2023083100271197500_euad226-B149","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ahj.2022.09.001","article-title":"Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: effects of the treatment timing on health status outcomes","volume":"254","author":"Nakamaru","year":"2022","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B150","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad051","article-title":"Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial","volume":"25","author":"Gottschalk","year":"2023","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B151","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B152","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B153","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.106.641225","article-title":"Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation","volume":"114","author":"Oral","year":"2006","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B154","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"2018 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"2023083100271197500_euad226-B155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jce.12387","article-title":"Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment","volume":"25","author":"Riley","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B156","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/jce.13822","article-title":"Anticoagulation after catheter ablation of atrial fibrillation: an unnecessary evil? A systematic review and meta-analysis","volume":"30","author":"Proietti","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B157","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1253\/circj.CJ-11-0065","article-title":"Incidence of late thromboembolic events after catheter ablation of atrial fibrillation","volume":"75","author":"Yagishita","year":"2011","journal-title":"Circ J"},{"key":"2023083100271197500_euad226-B158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/heartjnl-2011-300720","article-title":"Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death","volume":"98","author":"Hunter","year":"2012","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B159","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002597","article-title":"Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B161","first-page":"507","article-title":"Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials","volume":"12","author":"Zheng","year":"2015","journal-title":"J Geriatr Cardiol"},{"key":"2023083100271197500_euad226-B162","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00392-014-0804-1","article-title":"Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German ablation registry","volume":"104","author":"Nuhrich","year":"2015","journal-title":"Clin Res Cardiol"},{"key":"2023083100271197500_euad226-B163","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2459\/JCM.0000000000000311","article-title":"Long-term events following atrial fibrillation rate control or transcatheter ablation: a multicenter observational study","volume":"17","author":"Gallo","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2023083100271197500_euad226-B164","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jamacardio.2016.4179","article-title":"Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation","volume":"2","author":"Sj\u00e4lander","year":"2017","journal-title":"JAMA Cardiology"},{"key":"2023083100271197500_euad226-B165","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.hrthm.2017.02.001","article-title":"Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: a propensity score\u2013matched analysis","volume":"14","author":"Saliba","year":"2017","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B166","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005739","article-title":"CAABL-AF (California study of ablation for atrial fibrillation): mortality and stroke, 2005 to 2013","volume":"11","author":"Srivatsa","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B167","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/jce.13702","article-title":"Long-term risk of stroke and bleeding post-atrial fibrillation ablation","volume":"29","author":"Joza","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B168","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.4022\/jafib.2092","article-title":"Anticoagulation after catheter ablation of atrial fibrillation: is it time to discontinue in select patient population?","volume":"11","author":"Atti","year":"2018","journal-title":"J Atr Fibrillation"},{"key":"2023083100271197500_euad226-B169","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jce.14052","article-title":"Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: a systematic review and meta-analysis","volume":"30","author":"Romero","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007612","article-title":"Outcomes and anticoagulation use after catheter ablation for atrial fibrillation","volume":"12","author":"Freeman","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B171","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.amjcard.2020.09.036","article-title":"Thromboembolic risk of cessation of oral anticoagulation post catheter ablation in patients with and without atrial fibrillation recurrence","volume":"137","author":"Rong","year":"2020","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B172","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/europace\/euz235","article-title":"The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese atrial fibrillation registry study","volume":"22","author":"Yang","year":"2020","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B173","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/europace\/euaa235","article-title":"Atrial fibrillation and the risk of ischaemic strokes or intracranial haemorrhages: comparisons of the catheter ablation, medical therapy, and non-atrial fibrillation population","volume":"23","author":"Kim","year":"2021","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B174","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jce.14864","article-title":"Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation","volume":"32","author":"Pothineni","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B175","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221118480","article-title":"Benefits and risks associated with long-term oral anticoagulation after successful atrial fibrillation catheter ablation: systematic review and meta-analysis","volume":"28","author":"Maduray","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"2023083100271197500_euad226-B176","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jce.13476","article-title":"Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation","volume":"29","author":"Liang","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B177","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.109.875252","article-title":"Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400\u2005mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation\/atrial flutter","volume":"120","author":"Connolly","year":"2009","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B178","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/europace\/eus105","article-title":"Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation","volume":"14","author":"Lip","year":"2012","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B179","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/europace\/euu043","article-title":"Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey","volume":"16","author":"Chen","year":"2014","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (discern af): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2023083100271197500_euad226-B181","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","article-title":"Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence","volume":"112","author":"Hindricks","year":"2005","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B182","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1540-8159.2009.02357.x","article-title":"Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life","volume":"32","author":"Pontoppidan","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"2023083100271197500_euad226-B183","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/europace\/eux008","article-title":"Very long-term outcome following transcatheter ablation of atrial fibrillation. Are results maintained after 10 years of follow up?","volume":"20","author":"Gaita","year":"2018","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B184","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005250","article-title":"Ten-year clinical outcome after circumferential pulmonary vein isolation utilizing the Hamburg approach in patients with symptomatic drug-refractory paroxysmal atrial fibrillation","volume":"11","author":"Tilz","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B185","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.hrthm.2016.12.023","article-title":"Twelve-year follow-up of catheter ablation for atrial fibrillation: a prospective, multicenter, randomized study","volume":"14","author":"Bertaglia","year":"2017","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B186","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/europace\/euz339","article-title":"Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study","volume":"22","author":"De With","year":"2020","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B187","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjcard.2013.02.056","article-title":"Predictors of progression of recently diagnosed atrial fibrillation in REgistry on cardiac rhythm DisORDers assessing the control of atrial fibrillation (RecordAF); United States cohort","volume":"112","author":"Zhang","year":"2013","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B188","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B189","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B190","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2023083100271197500_euad226-B191","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.010304","article-title":"Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices","volume":"15","author":"Chew","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B192","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B193","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B194","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation\u2014the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"2023083100271197500_euad226-B195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B196","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment: implications for practice and clinical trial design","volume":"145","author":"Aguilar","year":"2022","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B197","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/pace.12389","article-title":"Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden","volume":"37","author":"Charitos","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"2023083100271197500_euad226-B198","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B199","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B200","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B201","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the mode selection trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B202","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B203","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCEP.114.003057","article-title":"Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices","volume":"8","author":"Turakhia","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B204","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1055\/s-0039-1683933","article-title":"Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially \u2018low-risk\u2019 patients","volume":"119","author":"Chao","year":"2019","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B205","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.hrthm.2018.06.027","article-title":"Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: results from the tailored anticoagulation for non-continuous atrial fibrillation (TACTIC-AF) pilot study","volume":"15","author":"Waks","year":"2018","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B206","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jce.12864","article-title":"Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the rhythm evaluation for anticoagulation with continuous monitoring (REACT.COM) pilot study","volume":"27","author":"Passman","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B207","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00392-015-0933-1","article-title":"Rationale and design of the ODIn-AF trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation","volume":"105","author":"Schrickel","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"2023083100271197500_euad226-B208","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The optimal anti-coagulation for enhanced-risk patients post-catheter ablation for atrial fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B209","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2022.05.003","article-title":"Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: rationale and design of the OPTION randomized trial","volume":"251","author":"Wazni","year":"2022","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jacc.2018.12.039","article-title":"Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation","volume":"73","author":"Conen","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B211","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/STROKEAHA.110.595082","article-title":"Microinfarct pathology, dementia, and cognitive systems","volume":"42","author":"Arvanitakis","year":"2011","journal-title":"Stroke"},{"key":"2023083100271197500_euad226-B212","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000341404","article-title":"Extensive white matter changes predict stroke recurrence up to 5 years after a first-ever ischemic stroke","volume":"34","author":"Melkas","year":"2012","journal-title":"Cerebrovascular Diseases"},{"key":"2023083100271197500_euad226-B213","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/jnnp.2008.154104","article-title":"Age related white matter changes predict stroke death in long term follow-up","volume":"80","author":"Oksala","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023083100271197500_euad226-B214","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"key":"2023083100271197500_euad226-B215","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.jacc.2021.04.012","article-title":"Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review","volume":"77","author":"Chen","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B216","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/europace\/euac237","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2019","volume":"25","author":"Dong","year":"2023","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B217","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111482","article-title":"Relationship between multimorbidity and outcomes in atrial fibrillation","volume":"153","author":"Proietti","year":"2021","journal-title":"Exp Gerontol"},{"key":"2023083100271197500_euad226-B218","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.mayocp.2019.06.012","article-title":"Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use","volume":"94","author":"Proietti","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2023083100271197500_euad226-B219","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12916-022-02526-7","article-title":"Clinical complexity and impact of the ABC (atrial fibrillation better care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational research programme in AF general long-term registry","volume":"20","author":"Romiti","year":"2022","journal-title":"BMC Med"},{"key":"2023083100271197500_euad226-B220","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12916-021-02120-3","article-title":"Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational research programme in AF (EORP-AF) general long-term registry","volume":"19","author":"Proietti","year":"2021","journal-title":"BMC Med"},{"key":"2023083100271197500_euad226-B221","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.885016","article-title":"Clustering of unhealthy lifestyle and the risk of adverse events in patients with atrial fibrillation","volume":"9","author":"Lee","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2023083100271197500_euad226-B222","doi-asserted-by":"crossref","first-page":"f329","DOI":"10.1093\/europace\/eux322","article-title":"Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK biobank cohort","volume":"20","author":"Jani","year":"2018","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B223","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101860","article-title":"Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis","volume":"57","author":"Chowdhury","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2023083100271197500_euad226-B224","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/07853890.2020.1799241","article-title":"Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey","volume":"53","author":"Koziel","year":"2021","journal-title":"Ann Med"},{"key":"2023083100271197500_euad226-B225","article-title":"Temporal trends and patterns in atrial fibrillation incidence: a population-based study of 3.4 million individuals","volume":"17","author":"Wu","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2023083100271197500_euad226-B226","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B227","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ajh\/hpz077","article-title":"Hypertension and atrial fibrillation: epidemiological data, pathogenesis, and therapeutic implications","volume":"32","author":"Liatakis","year":"2019","journal-title":"Am J Hypertens"},{"key":"2023083100271197500_euad226-B228","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2023083100271197500_euad226-B229","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/ajh\/hpx013","article-title":"Hypertension and atrial fibrillation: an intimate association of epidemiology, pathophysiology, and outcomes","volume":"30","author":"Dzeshka","year":"2017","journal-title":"Am J Hypertens"},{"key":"2023083100271197500_euad226-B230","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.120.16659","article-title":"Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study","volume":"77","author":"Lee","year":"2021","journal-title":"Hypertension"},{"key":"2023083100271197500_euad226-B231","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B232","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1378\/chest.11-0340","article-title":"A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade atrial fibrillation study","volume":"141","author":"Potpara","year":"2012","journal-title":"Chest"},{"key":"2023083100271197500_euad226-B233","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/eurheartj\/ehw077","article-title":"Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation","volume":"37","author":"Aspberg","year":"2016","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B234","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ajh\/hpx094","article-title":"Relationship of hypertension and systolic blood pressure with the risk of stroke or bleeding in patients with atrial fibrillation: the Fushimi AF registry","volume":"30","author":"Ishii","year":"2017","journal-title":"Am J Hypertens"},{"key":"2023083100271197500_euad226-B235","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B236","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/00015385.2021.1882111","article-title":"Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials","volume":"77","author":"Harskamp","year":"2022","journal-title":"Acta Cardiol"},{"key":"2023083100271197500_euad226-B237","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B238","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension","volume":"60","author":"Pokushalov","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B239","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"2023083100271197500_euad226-B240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2011.03.004","article-title":"Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation","volume":"108","author":"Huxley","year":"2011","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B241","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.ijcard.2013.07.234","article-title":"A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade atrial fibrillation study","volume":"168","author":"Potpara","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B242","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"2023083100271197500_euad226-B243","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2011.08.081","article-title":"Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes","volume":"156","author":"Chao","year":"2012","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B244","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"2023083100271197500_euad226-B245","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/europace\/euv214","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Anselmino","year":"2015","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B246","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jacep.2019.05.018","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"2023083100271197500_euad226-B247","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/jce.14954","article-title":"Effect of metformin on outcomes of catheter ablation for atrial fibrillation","volume":"32","author":"Deshmukh","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B248","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCULATIONAHA.116.024921","article-title":"Genetic obesity and the risk of atrial fibrillation: causal estimates from Mendelian randomization","volume":"135","author":"Chatterjee","year":"2017","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B249","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"Jama"},{"key":"2023083100271197500_euad226-B250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2023083100271197500_euad226-B251","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004378","article-title":"Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation","volume":"9","author":"Wong","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B252","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/eurheartj\/ehn324","article-title":"Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years","volume":"29","author":"Tsang","year":"2008","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B253","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.amjcard.2010.10.018","article-title":"Relation of obesity to recurrence rate and burden of atrial fibrillation","volume":"107","author":"Guglin","year":"2011","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B254","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11606-012-2220-4","article-title":"Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation","volume":"28","author":"Thacker","year":"2013","journal-title":"J Gen Intern Med"},{"key":"2023083100271197500_euad226-B255","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B256","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B257","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B258","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ahj.2015.07.026","article-title":"Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the look AHEAD randomized trial","volume":"170","author":"Alonso","year":"2015","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B259","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4172\/2167-0277.1000282","article-title":"Obstructive sleep apnea as a risk factor for atrial fibrillation: a meta-analysis","volume":"7","author":"Youssef","year":"2018","journal-title":"J Sleep Disord Ther"},{"key":"2023083100271197500_euad226-B260","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1378\/chest.15-0229","article-title":"Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort","volume":"148","author":"Cadby","year":"2015","journal-title":"Chest"},{"key":"2023083100271197500_euad226-B261","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjcard.2012.03.037","article-title":"Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter","volume":"110","author":"Monahan","year":"2012","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B262","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2011.02.343","article-title":"Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation","volume":"108","author":"Ng","year":"2011","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B263","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.amjcard.2015.08.046","article-title":"Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea","volume":"116","author":"Qureshi","year":"2015","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B264","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/01.CIR.0000068337.25994.21","article-title":"Obstructive sleep apnea and the recurrence of atrial fibrillation","volume":"107","author":"Kanagala","year":"2003","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ahj.2014.12.024","article-title":"Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"169","author":"Holmqvist","year":"2015","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B266","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.hrthm.2022.06.016","article-title":"Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial","volume":"19","author":"Hunt","year":"2022","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B267","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2018.11.100","article-title":"The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: a randomized controlled trial","volume":"278","author":"Caples","year":"2019","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B268","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.202011-4133OC","article-title":"Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: a randomized controlled trial","volume":"204","author":"Traaen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2023083100271197500_euad226-B269","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.108.785626","article-title":"Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study","volume":"118","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B270","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCOUTCOMES.110.951442","article-title":"Physical activity and the risk of incident atrial fibrillation in women","volume":"4","author":"Everett","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2023083100271197500_euad226-B271","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCEP.113.001244","article-title":"Physical activity, obesity, weight change, and risk of atrial fibrillation: the atherosclerosis risk in communities study","volume":"7","author":"Huxley","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023083100271197500_euad226-B272","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/heartjnl-2014-307145","article-title":"Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women","volume":"101","author":"Drca","year":"2015","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B273","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001127","article-title":"Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women","volume":"3","author":"Azarbal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B274","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.mayocp.2016.03.002","article-title":"Exercise capacity and atrial fibrillation risk in veterans: a cohort study","volume":"91","author":"Faselis","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2023083100271197500_euad226-B275","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B276","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/europace\/eup197","article-title":"Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis","volume":"11","author":"Abdulla","year":"2009","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B277","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/eurheartj\/eht188","article-title":"Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study","volume":"34","author":"Andersen","year":"2013","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B278","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jacc.2012.11.060","article-title":"Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA my heart study","volume":"61","author":"Lakkireddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B279","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2006.03.034","article-title":"Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation","volume":"116","author":"Hegbom","year":"2007","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B280","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2011.09.013","article-title":"A randomized study of the effects of exercise training on patients with atrial fibrillation","volume":"162","author":"Osbak","year":"2011","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B281","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1177\/2047487319859974","article-title":"Exercise-based cardiac rehabilitation for patients with catheter ablation for persistent atrial fibrillation: a randomized controlled clinical trial","volume":"26","author":"Kato","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2023083100271197500_euad226-B282","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B283","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170060","article-title":"Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation\u2014a randomized controlled trial","volume":"12","author":"Skielboe","year":"2017","journal-title":"PLoS One"},{"key":"2023083100271197500_euad226-B284","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004060","article-title":"Alcohol consumption, left atrial diameter, and atrial fibrillation","volume":"5","author":"McManus","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B285","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B286","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2017.05.133","article-title":"Alcohol and incident atrial fibrillation\u2014A systematic review and meta-analysis","volume":"246","author":"Gallagher","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B287","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007094","article-title":"Does moderate drinking increase the risk of atrial fibrillation? The Norwegian HUNT (Nord-Trondelag Health) study","volume":"6","author":"Gemes","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B288","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B289","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cjca.2013.12.026","article-title":"Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies","volume":"30","author":"Cheng","year":"2014","journal-title":"Can J Cardiol"},{"key":"2023083100271197500_euad226-B290","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/heartjnl-2013-303950","article-title":"Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"99","author":"Caldeira","year":"2013","journal-title":"Heart"},{"key":"2023083100271197500_euad226-B291","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000489843","article-title":"Does caffeine consumption increase the risk of new-onset atrial fibrillation?","volume":"140","author":"Abdelfattah","year":"2018","journal-title":"Cardiology"},{"key":"2023083100271197500_euad226-B292","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.eupc.2004.02.006","article-title":"The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation","volume":"7","author":"Mattioli","year":"2005","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B293","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.hrthm.2011.03.038","article-title":"Smoking and incidence of atrial fibrillation: results from the atherosclerosis risk in communities (ARIC) study","volume":"8","author":"Chamberlain","year":"2011","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B294","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2016.05.013","article-title":"Association of smoking with the risk of incident atrial fibrillation: a meta-analysis of prospective studies","volume":"218","author":"Zhu","year":"2016","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B295","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2023083100271197500_euad226-B296","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jce.13451","article-title":"Cigarette smoking causes a worse long-term outcome in persistent atrial fibrillation following catheter ablation","volume":"29","author":"Cheng","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023083100271197500_euad226-B297","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"Jama"},{"key":"2023083100271197500_euad226-B298","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B299","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised obesity reduction trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B300","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. Routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B301","first-page":"1187","article-title":"The atrial fibrillation therapies after ER visit: outpatient care for patients with acute AF\u2014the AFTER3 study","volume":"7","author":"Angaran","year":"2015","journal-title":"J Atr Fibrillation"},{"key":"2023083100271197500_euad226-B302","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/europace\/euab270","article-title":"Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial","volume":"24","author":"Nguyen","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B303","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/joa3.12555","article-title":"Revisiting the dynamic risk profile of cardiovascular\/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular\/non-cardiovascular outcomes: a machine-learning approach","volume":"37","author":"Lip","year":"2021","journal-title":"J Arrhythm"},{"key":"2023083100271197500_euad226-B304","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/eurheartj\/ehab672","article-title":"ESC And EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the horizon 2020 EHRA-PATHS project","volume":"43","author":"Heidbuchel","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B305","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B306","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B307","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B308","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"2023083100271197500_euad226-B309","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1093\/eurheartj\/ehz732","article-title":"Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials","volume":"40","author":"Gargiulo","year":"2019","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B310","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2019.1880","article-title":"Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized controlled trials","volume":"4","author":"Lopes","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2023083100271197500_euad226-B311","doi-asserted-by":"crossref","first-page":"f50","DOI":"10.1093\/ehjcvp\/pvaa116","article-title":"Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials","volume":"7","author":"Gargiulo","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2023083100271197500_euad226-B312","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017212","article-title":"Safety and efficacy of double antithrombotic therapy with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"9","author":"Capodanno","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B313","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1093\/eurheartj\/ehac294","article-title":"Great debate: triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week","volume":"43","author":"De Caterina","year":"2022","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B314","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00392-020-01760-4","article-title":"Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis","volume":"110","author":"Goette","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2023083100271197500_euad226-B315","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jacc.2022.04.058","article-title":"Presenting pattern of atrial fibrillation and outcomes of early rhythm control therapy","volume":"80","author":"Goette","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B316","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2020.06.046","article-title":"Differences in thromboembolic complications between paroxysmal and persistent atrial fibrillation patients following electrical cardioversion (from the ENSURE-AF study)","volume":"131","author":"Goette","year":"2020","journal-title":"Am J Cardiol"},{"key":"2023083100271197500_euad226-B317","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/CIRCULATIONAHA.119.044584","article-title":"Stent thrombosis in patients with atrial fibrillation undergoing coronary stenting in the AUGUSTUS trial","volume":"141","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B318","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B319","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2010.09.004","article-title":"The impact of rapid atrial pacing on ADMA and endothelial NOS","volume":"154","author":"Goette","year":"2012","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fmed.2019.00175","article-title":"Atrial fibrillation in older people: concepts and controversies","volume":"6","author":"Zathar","year":"2019","journal-title":"Front Med"},{"key":"2023083100271197500_euad226-B321","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","article-title":"Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review","volume":"79","author":"Volgman","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B322","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40256-020-00457-3","article-title":"Non-adherence to thromboprophylaxis guidelines in atrial fibrillation: a narrative review of the extent of and factors in guideline non-adherence","volume":"21","author":"Gebreyohannes","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"2023083100271197500_euad226-B323","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.42964","article-title":"Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010\u20132020","volume":"5","author":"Ko","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023083100271197500_euad226-B324","first-page":"771","article-title":"Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States medicare database","volume":"66","author":"Munir","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"2023083100271197500_euad226-B325","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001257","article-title":"Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis","volume":"7","author":"Gallagher","year":"2020","journal-title":"Open Heart"},{"key":"2023083100271197500_euad226-B326","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111455","article-title":"Describing the relationship between atrial fibrillation and frailty: clinical implications and open research questions","volume":"152","author":"Proietti","year":"2021","journal-title":"Exp Gerontol"},{"key":"2023083100271197500_euad226-B327","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Res Rev"},{"key":"2023083100271197500_euad226-B328","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/europace\/euac004","article-title":"Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis","volume":"24","author":"Diemberger","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B329","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017024","article-title":"Management of atrial fibrillation in older patients by morbidity burden: insights from get with the guidelines-atrial fibrillation","volume":"9","author":"Dalgaard","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjqcco\/qcaa070","article-title":"Treatment of older patients with atrial fibrillation by morbidity burden","volume":"8","author":"Rasmussen","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023083100271197500_euad226-B331","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.archger.2016.04.008","article-title":"The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation","volume":"65","author":"Mazzone","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"2023083100271197500_euad226-B332","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bcp.14464","article-title":"Patterns and factors influencing oral anticoagulant prescription in people with atrial fibrillation and dementia: results from UK primary care","volume":"87","author":"Mongkhon","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2023083100271197500_euad226-B333","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ehjqcco\/qcaa002","article-title":"Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation","volume":"7","author":"Gugganig","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023083100271197500_euad226-B334","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40266-021-00859-1","article-title":"Trends in anticoagulant use at nursing home admission and variation by frailty and chronic kidney disease among older adults with atrial fibrillation","volume":"38","author":"Campitelli","year":"2021","journal-title":"Drugs Aging"},{"key":"2023083100271197500_euad226-B335","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ageing\/afaa265","article-title":"Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study","volume":"50","author":"Wilkinson","year":"2021","journal-title":"Age Ageing"},{"key":"2023083100271197500_euad226-B336","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"key":"2023083100271197500_euad226-B337","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2018.09.017","article-title":"Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: insights from the ARISTOTLE trial","volume":"208","author":"Alexander","year":"2019","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B338","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ehjcvp\/pvz061","article-title":"Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial","volume":"6","author":"Nicolau","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2023083100271197500_euad226-B339","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1007\/s12325-021-01724-8","article-title":"Use of non-vitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and multimorbidity","volume":"38","author":"Deitelzweig","year":"2021","journal-title":"Adv Ther"},{"key":"2023083100271197500_euad226-B340","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s12325-022-02387-9","article-title":"Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and multimorbidity","volume":"40","author":"Dhamane","year":"2023","journal-title":"Adv Ther"},{"key":"2023083100271197500_euad226-B341","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ehjcvp\/pvaa117","article-title":"Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy","volume":"7","author":"Lip","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2023083100271197500_euad226-B342","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","author":"Zheng","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B343","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","author":"Grymonprez","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B344","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015089","article-title":"Polypharmacy, adverse outcomes, and treatment effectiveness in patients \u2265 75 with atrial fibrillation","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B345","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1161\/STROKEAHA.120.029541","article-title":"Comparative effectiveness of rivaroxaban, apixaban, and warfarin in atrial fibrillation patients with polypharmacy","volume":"5","author":"Mentias","year":"2020","journal-title":"Stroke"},{"key":"2023083100271197500_euad226-B346","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/jpm12030469","article-title":"Use and prescription of direct oral anticoagulants in older and frail patients with atrial fibrillation: a multidisciplinary consensus document","volume":"12","author":"Proietti","year":"2022","journal-title":"J Pers Med"},{"key":"2023083100271197500_euad226-B347","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.583311","article-title":"Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Grymonprez","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023083100271197500_euad226-B348","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/europace\/euac022","article-title":"Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis","volume":"24","author":"Wilkinson","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B349","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"key":"2023083100271197500_euad226-B350","article-title":"Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study","author":"Grymonprez","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2023083100271197500_euad226-B351","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/joim.13140","article-title":"Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study","volume":"289","author":"Lip","year":"2021","journal-title":"J Intern Med"},{"key":"2023083100271197500_euad226-B352","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"key":"2023083100271197500_euad226-B353","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","article-title":"Management of atrial high-rate episodes detected by cardiac implanted electronic devices","volume":"14","author":"Freedman","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"2023083100271197500_euad226-B354","first-page":"443","article-title":"Atrial high-rate episodes detected by cardiac implantable electronic devices: dynamic changes in episodes and predictors of incident atrial fibrillation","volume":"11","author":"Imberti","year":"2022","journal-title":"Biology (Basel)"},{"key":"2023083100271197500_euad226-B355","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/europace\/euab186","article-title":"Characteristics of patients with atrial high rate episodes detected by implanted defibrillator and resynchronization devices","volume":"24","author":"Miyazawa","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B356","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2022.06.023","article-title":"Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression","volume":"103","author":"Proietti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B357","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ijcp.12326","article-title":"AF Burden is important\u2014fact or fiction?","volume":"68","author":"Boriani","year":"2014","journal-title":"Int J Clin Pract"},{"key":"2023083100271197500_euad226-B358","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of &gt;10,000 patients from the SOS AF project (stroke preventiOn strategies based on atrial fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"2023083100271197500_euad226-B359","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.04.023","article-title":"Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations","volume":"101","author":"Imberti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.31083\/j.rcm2302056","article-title":"Evidence-based treatment of atrial fibrillation around the globe: comparison of the latest ESC, AHA\/ACC\/HRS, and CCS guidelines on the management of atrial fibrillation","volume":"23","author":"Wolfes","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"2023083100271197500_euad226-B361","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.3390\/jcm10173979","article-title":"Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients","volume":"10","author":"Sgreccia","year":"2021","journal-title":"J Clin Med"},{"key":"2023083100271197500_euad226-B362","doi-asserted-by":"crossref","first-page":"O42","DOI":"10.1093\/eurheartj\/suaa179","article-title":"What do we do about atrial high rate episodes?","volume":"22","author":"Boriani","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"2023083100271197500_euad226-B363","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/europace\/euz172","article-title":"Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence","volume":"21","author":"Bertaglia","year":"2019","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B364","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/a-1346-2899","article-title":"Atrial fibrillation in patients with embolic stroke of undetermined source during 3 years of prolonged monitoring with an implantable loop recorder","volume":"121","author":"Kitsiou","year":"2021","journal-title":"Thromb Haemost"},{"key":"2023083100271197500_euad226-B365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejim.2021.05.038","article-title":"Device-detected atrial high rate episodes and the risk of stroke\/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis","volume":"92","author":"Vitolo","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B366","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.hrthm.2017.11.007","article-title":"Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden","volume":"15","author":"Boriani","year":"2018","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B367","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/europace\/euac144","article-title":"Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper","volume":"25","author":"Kalarus","year":"2023","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B368","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejim.2022.11.015","article-title":"Natural history of \u2018silent\u2019 atrial fibrillation from subclinical to asymptomatic: state of the art and need for research","volume":"107","author":"Proietti","year":"2023","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B369","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/europace\/euac123","article-title":"EHRA Expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)","volume":"25","author":"Savelieva","year":"2023","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B370","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2016.03.006","article-title":"Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation","volume":"83","author":"Boriani","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"2023083100271197500_euad226-B371","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2019.07.039","article-title":"Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN group","volume":"296","author":"Boriani","year":"2019","journal-title":"Int J Cardiol"},{"key":"2023083100271197500_euad226-B372","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11886-021-01487-2","article-title":"Remote monitoring and telemedicine in heart failure: implementation and benefits","volume":"23","author":"Imberti","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"2023083100271197500_euad226-B373","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/europace\/euab160","article-title":"Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality","volume":"24","author":"Ahmed","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B374","article-title":"Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices","author":"Boriani","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B375","doi-asserted-by":"crossref","first-page":"353","DOI":"10.31083\/j.rcm2202042","article-title":"Thromboembolic risk stratification in atrial fibrillation-beyond clinical risk scores","volume":"22","author":"Wan","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"2023083100271197500_euad226-B376","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s11739-020-02551-5","article-title":"Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation","volume":"16","author":"Malavasi","year":"2021","journal-title":"Intern Emerg Med"},{"key":"2023083100271197500_euad226-B377","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/europace\/euab280","article-title":"Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF long-term general registry","volume":"24","author":"Ding","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B378","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/17434440.2022.2070005","article-title":"Mobile health technology in atrial fibrillation","volume":"19","author":"Bonini","year":"2022","journal-title":"Expert Rev Med Devices"},{"key":"2023083100271197500_euad226-B379","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead031","article-title":"Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence","volume":"3","author":"Corica","year":"2023","journal-title":"Eur Heart J Open"},{"key":"2023083100271197500_euad226-B380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002903","article-title":"Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals","volume":"16","author":"Lowres","year":"2019","journal-title":"PLoS Med"},{"key":"2023083100271197500_euad226-B381","first-page":"3394","article-title":"Monitoring and detecting atrial fibrillation using wearable technology","volume":"2016","author":"Nemati","year":"2016","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"2023083100271197500_euad226-B382","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008585","article-title":"Contact-Free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals","volume":"7","author":"Yan","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2023083100271197500_euad226-B383","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/europace\/euy176","article-title":"Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO)","volume":"21","author":"Brasier","year":"2019","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B384","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"Mobile photoplethysmographic technology to detect atrial fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023083100271197500_euad226-B385","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Apple heart study I. Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N Engl J Med"},{"key":"2023083100271197500_euad226-B386","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/europace\/euz119","article-title":"Atrial fibrillation screening with photo-plethysmography through a smartphone camera","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B387","doi-asserted-by":"crossref","DOI":"10.2196\/14909","article-title":"Validation of single centre pre-mobile atrial fibrillation apps for continuous monitoring of atrial fibrillation in a real-world setting: pilot cohort study","volume":"21","author":"Zhang","year":"2019","journal-title":"J Med Internet Res"},{"key":"2023083100271197500_euad226-B388","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.hrthm.2020.01.034","article-title":"A new smart wristband equipped with an artificial intelligence algorithm to detect atrial fibrillation","volume":"17","author":"Chen","year":"2020","journal-title":"Heart Rhythm"},{"key":"2023083100271197500_euad226-B389","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.122.060291","article-title":"Detection of atrial fibrillation in a large population using wearable devices: the fitbit heart study","volume":"146","author":"Lubitz","year":"2022","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B390","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41591-022-01979-w","article-title":"Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial","volume":"28","author":"Rizas","year":"2022","journal-title":"Nat Med"},{"key":"2023083100271197500_euad226-B391","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ahj.2023.01.004","article-title":"Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the heartline study","volume":"259","author":"Gibson","year":"2023","journal-title":"Am Heart J"},{"key":"2023083100271197500_euad226-B392","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/CIRCULATIONAHA.119.040267","article-title":"Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN international collaboration","volume":"140","author":"Schnabel","year":"2019","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B393","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2021.06.022","article-title":"Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors","volume":"92","author":"Ungar","year":"2021","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B394","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.121.058911","article-title":"Consumer-led screening for atrial fibrillation: frontier review of the AF-SCREEN international collaboration","volume":"146","author":"Brandes","year":"2022","journal-title":"Circulation"},{"key":"2023083100271197500_euad226-B395","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/europace\/euab036","article-title":"Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial","volume":"23","author":"Koh","year":"2021","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B396","first-page":"739","article-title":"Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: the INFO-COVID survey","volume":"18","author":"Boriani","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"2023083100271197500_euad226-B397","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejim.2020.09.005","article-title":"Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: a survey of health care professionals by AF-SCREEN international collaboration","volume":"82","author":"Boriani","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2023083100271197500_euad226-B398","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/europace\/euac142","article-title":"Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey","volume":"24","author":"Boriani","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B399","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/euac038","article-title":"How to use digital devices to detect and manage arrhythmias: an EHRA practical guide","volume":"24","author":"Svennberg","year":"2022","journal-title":"Europace"},{"key":"2023083100271197500_euad226-B400","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jpm13010099","article-title":"Digital health literacy after COVID-19 outbreak among frail and non-frail cardiology patients: the DIGI-COVID study","volume":"13","author":"Vitolo","year":"2022","journal-title":"J Pers Med"},{"key":"2023083100271197500_euad226-B401","article-title":"Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review","author":"Lane","journal-title":"Europace"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad226\/51309952\/euad226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad226\/51309952\/euad226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T20:28:51Z","timestamp":1693427331000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad226\/7248712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":401,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad226","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,8,2]]},"article-number":"euad226"}}